Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2021 first-quarter earnings
Lede-What You Need to Know About Johnson & Johnson's 2021 First-Quarter Earnings.jpg

What you need to know about Johnson & Johnson’s 2021 first-quarter earnings

Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

90.png

This morning, Johnson & Johnson shared its first-quarter performance.

For more than 130 years, the company has aimed to make people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, with approximately 135,000 employees across the globe, the organization is striving to put a healthy mind, body and environment within reach of everyone, everywhere.

“Our strong first-quarter performance was primarily driven by above market growth in our pharmaceutical segment and continued recovery in our medical device unit,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are more confident than ever in the resilience of our diversified portfolio and the unwavering commitment of our Johnson & Johnson colleagues to deliver life-enhancing medicines and products to patients and customers around the globe. We remain focused on creating long-term value for all our stakeholders and investing in innovation that helps to further our goal of changing the trajectory of health for humanity.”

For more details about the company’s 2021 first-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


2021 Johnson & Johnson First Quarter Earnings Infographic

Johnson & Johnson’s 2021 1st-Quarter Earnings

Read the earnings press release, which includes full financial details for the first quarter of 2021.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.